ROR-PH-303 ADVANCE EXTENSION - A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects with PAH via an Open-Label Extension

NCT03683186

ADVANCE EXTENSION - A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects with PAH via an Open-Label Extension

Principal Investigator

Sponsor

United Therapeutics

If you have taken part in a research study with ralinepag, the investigational study drug, you may be able to take part in this extension study. This means that all participants will receive the investigational study drug to look at its safety and effects when used with your current oral PAH treatments over a longer period.